2.03
price down icon1.45%   -0.04
 
loading

Jaguar Health Inc Aktie (JAGX) Neueste Nachrichten

pulisher
03:55 AM

Will Jaguar Health Inc. stock pay special dividends2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com

03:55 AM
pulisher
Oct 12, 2025

FDA-Authorized Expanded Access Programs Utilizing Jaguar Health's Novel Crofelemer Powder for Oral Solution to Treat Two Pediatric Intestinal Failure Patients with Microvillus Inclusion Disease - Worcester Telegram

Oct 12, 2025
pulisher
Oct 12, 2025

Evaluating Jaguar Health Inc. with trendline analysis2025 Market Outlook & Daily Stock Momentum Reports - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Analyzing Jaguar Health Inc. with risk reward ratio chartsJuly 2025 Reactions & Consistent Income Trade Recommendations - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Price action breakdown for Jaguar Health Inc.Quarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Jaguar Health Presenting September 25 at Emerging Growth Conference and September 30 at Lytham Partners Fall 2025 Conference to Provide Updates on Near-Term Catalysts - Lansing State Journal

Oct 12, 2025
pulisher
Oct 12, 2025

Jaguar Health Presenting at September 8-10 H.C. Wainwright Annual Global Investment Conference to Provide Updates on Near-Term Catalysts - Peoria Journal Star

Oct 12, 2025
pulisher
Oct 11, 2025

Jaguar Health Submits Orphan Drug Designation Application to FDA for Crofelemer for Cancer Therapy-Related Diarrhea (CTD) in Patients with Breast Cancer with Metastasis Identified by FDA as a Distinct Condition - Shreveport Times

Oct 11, 2025
pulisher
Oct 10, 2025

Using fundamentals and technicals on Jaguar Health Inc.Exit Point & High Win Rate Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Chart based analysis of Jaguar Health Inc. trendsQuarterly Trade Review & Stock Market Timing Techniques - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:56:36 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Real time social sentiment graph for Jaguar Health Inc.New Guidance & AI Driven Stock Movement Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What machine learning models say about Jaguar Health Inc.July 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Momentum divergence signals in Jaguar Health Inc. chartWatch List & Free Verified High Yield Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs - ACCESS Newswire

Oct 09, 2025
pulisher
Oct 09, 2025

How to build a custom watchlist for Jaguar Health Inc.New Guidance & Long-Term Safe Investment Plans - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Tools to assess Jaguar Health Inc.’s risk profile2025 Bull vs Bear & Growth Focused Entry Point Reports - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Jaguar Health registers 2.62M shares for resale following private placements - MSN

Oct 08, 2025
pulisher
Oct 07, 2025

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - ACCESS Newswire

Oct 07, 2025
pulisher
Oct 07, 2025

Jaguar Health Completes Meeting with FDA for Advice on Development Pathways to Advance Ongoing Crofelemer Trial for Potential Approval for Treatment of Pediatric Indication Microvillus Inclusion Disease (MVID) - The Florida Times-Union

Oct 07, 2025
pulisher
Oct 06, 2025

Jaguar Health reports positive results in MVID treatment trial By Investing.com - Investing.com Nigeria

Oct 06, 2025
pulisher
Oct 06, 2025

Jaguar Health reports positive results in MVID treatment trial - Investing.com

Oct 06, 2025
pulisher
Oct 06, 2025

Jaguar Health (JAGX) Advances Crofelemer Trial Following FDA Mee - GuruFocus

Oct 06, 2025
pulisher
Oct 06, 2025

37% PS reduction; Jaguar Health's crofelemer powder reduced TPN 30% in pediatric MVID trial - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Is Jaguar Health Inc. stock a buy before product launchesWeekly Volume Report & Low Risk Entry Point Tips - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Can technical indicators confirm Jaguar Health Inc.’s reversalJuly 2025 EndofMonth & Low Risk Entry Point Tips - newser.com

Oct 05, 2025
$84.77
price up icon 1.17%
$22.80
price up icon 6.79%
$32.66
price up icon 2.62%
$102.67
price up icon 0.63%
$165.97
price up icon 2.26%
biotechnology ONC
$331.14
price up icon 3.60%
Kapitalisierung:     |  Volumen (24h):